-
indications was ending, and in 2009 it
announced that it was
discontinuing Zenapax worldwide "in view of
available alternative treatments and the diminishing...
- Klonopin, Kytril, Naprosyn, Rocephin, Roferon-A, Romazicon, Valium, Xenical,
Zenapax Revenue $26.4
billion (2020)
Number of
employees 13,539 (July 2021) Parent...
-
Zelboraf (vemurafenib), for late-stage V600E BRAF mutation-positive melanoma.
Zenapax (daclizumab), for the
prevention of
acute transplant rejection. Diabetes...
- anti-Tac
antibodies in the year 1998:
basiliximab (Simulect) and
daclizumab (
Zenapax).
These drugs act by
binding the IL-2a receptor's α chain,
preventing the...
-
intravenous chimeric EGFR
Metastatic colorectal carcinoma 125084 Link
daclizumab Zenapax Roche 12/10/1997
intravenous humanized IL2RA
Prophylaxis of
acute organ...
- CD70
cancer Dacetuzumab mab
humanized CD40
hematologic cancers Daclizumab Zenapax mab
humanized CD25 (α
chain of IL-2 receptor) Y
prevention of
organ transplant...
-
protocol uses a
combination of
immunosuppressive drugs,
including daclizumab (
Zenapax),
sirolimus (Rapamune) and
tacrolimus (Prograf).
Daclizumab is
given intravenously...
-
cytokine receptor to
receive FDA approval),
humanized anti-Tac (daclizumab,
Zenapax) and the
antibody armed with
toxins or
alpha and beta-emitting radionuclides...
-
Zelboraf Zelnorm Zelsuvmi Zemaira Zembrace Symtouch Zemdri Zemplar Zemuron Zenapax zenarestat (INN)
Zenatane zeniplatin (INN)
zepastine (INN)
Zepatier Zepbound...
